Trial NCT04871542

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

This study examines how certain risk factors (such as age, gender, other medical conditions,
and the type of immunotherapy used to treat the cancer) affect whether a patient with a
malignant solid tumor will develop mild or serious side effects from the immunotherapy
medications. Immunotherapy is the type of treatment that helps the body's immune system fight
cancer. In the future, this information may help doctors make better decisions about cancer


Biospecimen Collection, Questionnaire Administration


Malignant Solid Neoplasm


Krishna S Gunturu, Debra M. Prow

See list of participating sites